This study has found significant relationships between the blood concentration of two endocannabinoid neurotransmitters with clinical variables and body mass index (BMI) in a group of patients with extreme clinical weight conditions.
The results show that a protein, NADPH oxidase NOX4, which had been described as a mediator of TGF-beta-induced cell death, also participates in the pro-tumorogenic response to this factor, specifically mediating its pro-migratory and invasive effects.
According to the study carried out by the IDIBELL research group on cardiovascular diseases (BIOHEART), this program not only could reduce hospital admissions and deaths of patients 30 days after discharge – as it was already proven – but also at 90 and 180 days.
The Bellvitge Hospital, Primary Care and IDIBELL have analyzed the cases of more than 77,500 heart failure patients in Catalonia between 2015 and 2019.
In a phase 2 clinical trial, researchers have observed that this combination allows to carry out global treatment from the beginning, manages to keep metastases stable for 7
Led by the Centre for Research and Technology Hellas (CERTH), the project includes 27 complementary partners from different research domains. This initiative integrates cutting-edge research methodologies powered by artificial intelligence to deliver personalized, evidence-based approaches for preventing this type of cancer.
Dr. Josep Manuel Menchon, group leader at IDIBELL and head of the Psychiatry Service at Bellvitge University Hospital, participates in a pioneering study led by the University of Hertfordshire to address and reduce the risks of harmful Internet use among adolescents.
New research will look for risk indicators of harmful internet use among adolescents Read More »
The article by Juvé and Adamuz highlights the importance of knowledge of nursing tools and strategies (ATIC and ARES) to improve patient outcomes and the work environment.
The participation of Institute students in the IDIBELL sLHam for women scientists, the creation of a new Sant Jordi award or the co-creation of content and activities for the new Biomedicine subject have been the main novelties of the course.
According to the results of the APRIL study, in which the Hospital de Bellvitge and IDIBELL have participated, ApTOLL has shown good safety in 151 patients with acute ischemic stroke.
A new neuroprotective drug shows good preliminary results for ischemic stroke Read More »
